1. Lopes-Ramos CM, Chen CY, Kuijjer ML, Paulson JN, Sonawane AR, Fagny M, et al. Sex differences in gene expression and regulatory networks across 29 human tissues. Cell Rep. 2020 Jun;31(12):107795. DOI: 10.1016/j.celrep.2020.107795

2. Glass D, Viñuela A, Davies MN, Ramasamy A, Parts L, Knowles D, et al. Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol. 2013 Jul;14(7):R75. DOI: 10.1186/gb-2013-14-7-r75

3. Farhud D, Zarif Yeganeh M, Zarif Yeganeh M. Nutrigenomics and nutrigenetics. Iran J Public Health. 2010;39(4):1-14.

4. Rider CF, Carlsten C. Air pollution and DNA methylation: effects of exposure in humans. Clin Epigenetics. 2019 Sep;11(1):131. DOI: 10.1186/s13148-019-0713-2

5. Ji H, Khurana Hershey GK. Genetic and epigenetic influence on the response to environmental particulate matter. J Allergy Clin Immunol. 2012 Jan;129(1):33-41. DOI: 10.1016/j.jaci.2011.11.008

6. Zannas AS, Arloth J, Carrillo-Roa T, Iurato S, Röh S, Ressler KJ, et al. Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. Genome Biol. 2015 Dec;16:266. DOI: 10.1186/s13059-015-0828-5

7. Vaiserman AM. Epigenetic programming by early-life stress: Evidence from human populations. Dev Dyn. 2015 Mar;244(3):254-265. DOI: 10.1002/dvdy.24211

8. Howie H, Rijal CM, Ressler KJ. A review of epigenetic contributions to post-traumatic stress disorder. Dialogues Clin Neurosci. 2019 Dec;21(4):417-428. DOI: 10.31887/DCNS.2019.21.4/kressler

9. Lehrner A, Yehuda R. Cultural trauma and epigenetic inheritance. Dev Psychopathol. 2018 Dec;30(5):1763-1777. DOI: 10.1017/S0954579418001153

10. Yehuda R, Lehrner A. Intergenerational transmission of trauma effects: putative role of epigenetic mechanisms. World Psychiatry. 2018 Oct;17(3):243-257. DOI: 10.1002/wps.20568

11. Gaine ME, Chatterjee S, Abel T. Sleep deprivation and the epigenome. Front Neural Circuits. 2018;12:14. DOI: 10.3389/fncir.2018.00014

12. Plaza-Diaz J, Izquierdo D, Torres-Martos Á, Baig AT, Aguilera CM, Ruiz-Ojeda FJ. Impact of physical activity and exercise on the epigenome in skeletal muscle and effects on systemic metabolism. Biomedicines. 2022 Jan;10(1):126. DOI: 10.3390/biomedicines10010126

13. Zakhari S. Alcohol metabolism and epigenetics changes. Alcohol Res. 2013;35(1):6-16. DOI: 10.2217/epi.11.22

14. Joehanes R, Just AC, Marioni RE, Pilling LC, Reynolds LM, Mandaviya PR, et al. Epigenetic signatures of cigarette smoking. Circ Cardiovasc Genet. 2016 Oct;9(5):436-447. DOI: 10.1161/CIRCGENETICS.116.001506

15. Knopik VS, Maccani MA, Francazio S, McGeary JE. The epigenetics of maternal cigarette smoking during pregnancy and effects on child development. Dev Psychopathol. 2012 Nov;24(4):1377-1390. DOI: 10.1017/S0954579412000776

16. Toth M. Epigenetic neuropharmacology: drugs affecting the epigenome in the brain. Annu Rev Pharmacol Toxicol. 2021 Jan;61:181-201. DOI: 10.1146/annurev-pharmtox-030220-022920

17. Wong CCY, Mill J, Fernandes C. Drugs and addiction: an introduction to epigenetics. Addiction. 2011 Mar;106(3):480-489. DOI: 10.1111/j.1360-0443.2010.03321.x

18. Woo V, Alenghat T. Epigenetic regulation by gut microbiota. Gut Microbes. 2022;14(1):2022407. DOI: 10.1080/19490976.2021.2022407

19. Al Aboud NM, Tupper C, Jialal I. Genetics, epigenetic mechanism [Internet]. Treasure Island: StatPearls; 2023 [cited 2025 Jun 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532999/

20. Hing B, Gardner C, Potash JB. Effects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet. 2014 Oct;165B(7):541-554. DOI: 10.1002/ajmg.b.32265

21. Reynolds EH, Carney MW, Toone BK. Methylation and mood. Lancet. 1984 Jul;2(8396):196-198. DOI: 10.1016/s0140-6736(84)90482-3

22. Stankiewicz AM, Swiergiel AH, Lisowski P. Epigenetics of stress adaptations in the brain. Brain Res Bull. 2013 Sep;98:76-92. DOI: 10.1016/j.brainresbull.2013.07.003

23. Guo Y, Yu S, Zhang C, Kong ANT. Epigenetic regulation of Keap1-Nrf2 signaling. Free Radic Biol Med. 2015 Nov;88(Pt B):337-349. DOI: 10.1016/j.freeradbiomed.2015.06.013

24. Unnikrishnan A, Freeman WM, Jackson J, Wren JD, Porter H, Richardson A. The role of DNA methylation in epigenetics of aging. Pharmacol Ther. 2019 Mar;195:172-185. DOI: 10.1016/j.pharmthera.2018.11.001

25. Pal S, Tyler JK. Epigenetics and aging. Sci Adv. 2016 Jul;2(7):e1600584. DOI: 10.1126/sciadv.1600584

26. Zhang S, Meng Y, Zhou L, Qiu L, Wang H, Su D, et al. Targeting epigenetic regulators for inflammation: mechanisms and intervention therapy. MedComm (2020). 2022 Dec;3(4):e173. DOI: 10.1002/mco2.173

27. Morales-Nebreda L, McLafferty FS, Singer BD. DNA methylation as a transcriptional regulator of the immune system. Transl Res. 2019 Feb;204:1-18. DOI: 10.1016/j.trsl.2018.08.001

28. Lu AT, Quach A, Wilson JG, Reiner AP, Aviv A, Raj K, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY). 2019 Jan;11(2):303-327. DOI: 10.18632/aging.101684

29. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995 May;10(1):111-113. DOI: 10.1038/ng0595-111

30. Mazokopakis EE, Papadomanolaki MG, Papadakis JA. The effects of folinic acid and l-methylfolate supplementation on serum total homocysteine levels in healthy adults. Clin Nutr ESPEN. 2023 Dec;58:14-20. DOI: 10.1016/j.clnesp.2023.09.002

31. Ledowsky CJ, Schloss J, Steel A. Variations in folate prescriptions for patients with the MTHFR genetic polymorphisms: a case series study. Explor Res Clin Soc Pharm. 2023 Jun;10:100277. DOI: 10.1016/j.rcsop.2023.100277

32. Goyco Ortiz LE, Servy EJ, Menezo YJR. A successful treatment with 5 methyltetrahydrofolate of a 677 TT MTHFR woman suffering premature ovarian insufficiency post a NHL (non-Hodgkin's lymphoma) and RPL (repeat pregnancy losses). J Assist Reprod Genet. 2019 Jan;36(1):65-67. DOI: 10.1007/s10815-018-1332-0

33. MTHFR Support Australia. The folic acid vs 5-MTHF debate [Internet]. Neurtral Bay: MTHFR Support Australia; 2015 [cited 2025 Jun 24]. Available from: https://www.mthfrsupport.com.au/2015/05/folic-acid-vs-5-mthf-debate/

34. Inxight Drugs. Levomefolic acid [Internet]. Washington, D.C.: U.S. Department of Health & Human Services; 2010 [cited 2025 Jun 24]. Available from: https://drugs.ncats.io/drug/8S95DH25XC

35. Raghubeer S, Matsha TE. Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and cardiovascular risks. Nutrients. 2021 Dec;13(12):4562. DOI: 10.3390/nu13124562

36. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002 Oct;288(16):2023-2031. DOI: 10.1001/jama.288.16.2023

37. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 2007 Jan;165(1):1-13. DOI: 10.1093/aje/kwj347

38. Lewis SJ, Lawlor DA, Davey Smith G, Araya R, Timpson N, Day INM, et al. The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol Psychiatry. 2006 Apr;11(4):352-360. DOI: 10.1038/sj.mp.4001790

39. Gong M, Dong W, He T, Shi Z, Huang G, Ren R, et al. MTHFR 677C>T polymorphism increases the male infertility risk: a meta-analysis involving 26 studies. PLoS One. 2015;10(3):e0121147. DOI: 10.1371/journal.pone.0121147

40. Huang LL, Tong JR, Huang Y, Wei YN, Chen HF, Chen Y, et al. Association of MTHFR gene C677T polymorphism with pregnancy outcome. Eur Rev Med Pharmacol Sci. 2023 Jan;27(1):166-171. DOI: 10.26355/eurrev_202301_30868

41. Xu Y, Ban Y, Ran L, Yu Y, Zhai S, Sun Z, et al. Relationship between unexplained recurrent pregnancy loss and 5,10-methylenetetrahydrofolate reductase) polymorphisms. Fertil Steril. 2019 Mar;111(3):597-603. DOI: 10.1016/j.fertnstert.2018.11.011

42. D'Elia PQ, Dos Santos AA, Bianco B, Barbosa CP, Christofolini DM, Aoki T. MTHFR polymorphisms C677T and A1298C and associations with IVF outcomes in Brazilian women. Reprod Biomed Online. 2014 Jun;28(6):733-738. DOI: 10.1016/j.rbmo.2014.02.005

43. Pokushalov E, Ponomarenko A, Bayramova S, Garcia C, Pak I, Shrainer E, et al. Effect of methylfolate, pyridoxal-5'-phosphate, and methylcobalamin (SolowaysTM) supplementation on homocysteine and low-density lipoprotein cholesterol levels in patients with methylenetetrahydrofolate reductase, methionine synthase, and methionine synthase reductase polymorphisms: a randomized controlled trial. Nutrients. 2024 May;16(11):1550. DOI: 10.3390/nu16111550

44. Chiuve SE, Giovannucci EL, Hankinson SE, Zeisel SH, Dougherty LW, Willett WC, et al. The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am J Clin Nutr. 2007 Oct;86(4):1073-1081. DOI: 10.1093/ajcn/86.4.1073

45. Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA, et al. Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr. 2006 Apr;83(4):905-911. DOI: 10.1093/ajcn/83.4.905

46. Healthline. MTHFR gene mutation [Internet]. San Francisco: Healthline; 2025 [cited 2025 Jul 3]. Available from: https://www.healthline.com/health/mthfr-gene

47. Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl). 2016 Jul;94(7):739-746. DOI: 10.1007/s00109-016-1427-y

48. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013 Feb;9(2):106-118. DOI: 10.1038/nrneurol.2012.263

49. Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, et al. Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: a review. JAMA Neurol. 2017 Mar;74(3):339-347. DOI: 10.1001/jamaneurol.2016.4899

50. Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-221. DOI: 10.3945/ajcn.114.103283

51. Norwitz NG, Saif N, Ariza IE, Isaacson RS. Precision nutrition for Alzheimer's prevention in ApoE4 carriers. Nutrients. 2021 Apr;13(4):1362. DOI: 10.3390/nu13041362

52. Carrillo JÁ, Arcusa R, Xandri-Martínez R, Cerdá B, Zafrilla P, Marhuenda J. Impact of polyphenol-rich nutraceuticals on cognitive function and neuroprotective biomarkers: a randomized, double-blind, placebo-controlled clinical trial. Nutrients. 2025 Feb;17(4):601. DOI: 10.3390/nu17040601

53. Rusanen M, Rovio S, Ngandu T, Nissinen A, Tuomilehto J, Soininen H, et al. Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study. Dement Geriatr Cogn Disord. 2010;30(3):277-284. DOI: 10.1159/000320484

54. Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, et al. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry. 2007 Sep;62(5):472-478. DOI: 10.1016/j.biopsych.2007.03.013

55. Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C, et al. Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure. J Stroke Cerebrovasc Dis. 2013 Feb;22(2):119-125. DOI: 10.1016/j.jstrokecerebrovasdis.2011.06.020

56. Kaufman CS, Honea RA, Pleen J, Lepping RJ, Watts A, Morris JK, et al. Aerobic exercise improves hippocampal blood flow for hypertensive apolipoprotein E4 carriers. J Cereb Blood Flow Metab. 2021 Aug;41(8):2026-2037. DOI: 10.1177/0271678X21990342

57. Tokgöz S, Claassen JAHR. Exercise as potential therapeutic target to modulate Alzheimer's disease pathology in APOE ε4 carriers: a systematic review. Cardiol Ther. 2021 Jun;10(1):67-88. DOI: 10.1007/s40119-020-00209-z

58. Lim ASP, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec;70(12):1544-1551. DOI: 10.1001/jamaneurol.2013.4215

59. Zhang Y, Fu S, Ding D, Lutz MW, Zeng Y, Yao Y. Leisure activities, APOE ε4, and cognitive decline: a longitudinal cohort study. Front Aging Neurosci. 2021;13:736201. DOI: 10.3389/fnagi.2021.736201

60. Oberlin LE, Manuck SB, Gianaros PJ, Ferrell RE, Muldoon MF, Jennings JR, et al. Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample. Neuropsychology. 2015 Sep;29(5):693-702. DOI: 10.1037/neu0000177

61. Bender AR, Raz N. Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure. Neuropsychologia. 2012 Apr;50(5):704-714. DOI: 10.1016/j.neuropsychologia.2011.12.025

62. Gough SC, Simmonds MJ. The HLA region and autoimmune disease: associations and mechanisms of action. Curr Genomics. 2007 Nov;8(7):453-465. DOI: 10.2174/138920207783591690

63. Lee YH, Bae SC, Song GG. Gene-environmental interaction between smoking and shared epitope on the development of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: a meta-analysis. Int J Rheum Dis. 2014 Jun;17(5):528-535. DOI: 10.1111/1756-185X.12307

64. Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2010 Jan;69(1):54-60. DOI: 10.1136/ard.2008.102962

65. Johansson K, Askling J, Alfredsson L, Di Giuseppe D. Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study. Arthritis Res Ther. 2018 Aug;20(1):175. DOI: 10.1186/s13075-018-1680-2

66. Gan RW, Demoruelle MK, Deane KD, Weisman MH, Buckner JH, Gregersen PK, et al. Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis. Ann Rheum Dis. 2017 Jan;76(1):147-152. DOI: 10.1136/annrheumdis-2016-209154

67. Norris JM, Yin X, Lamb MM, Barriga K, Seifert J, Hoffman M, et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA. 2007 Sep;298(12):1420-1428. DOI: 10.1001/jama.298.12.1420

68. Savastio S, Cadario F, D'Alfonso S, Stracuzzi M, Pozzi E, Raviolo S, et al. Vitamin D supplementation modulates ICOS+ and ICOS- regulatory T cell in siblings of children with type 1 diabetes. J Clin Endocrinol Metab. 2020 Dec;105(12):dgaa588. DOI: 10.1210/clinem/dgaa588

69. Handunnetthi L, Ramagopalan SV, Ebers GC. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology. 2010 Jun;74(23):1905-1910. DOI: 10.1212/WNL.0b013e3181e24124

70. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 Feb;5(2):e1000369. DOI: 10.1371/journal.pgen.1000369

71. Lamb MM, Yin X, Barriga K, Hoffman MR, Barón AE, Eisenbarth GS, et al. Dietary glycemic index, development of islet autoimmunity, and subsequent progression to type 1 diabetes in young children. J Clin Endocrinol Metab. 2008 Oct;93(10):3936-3942. DOI: 10.1210/jc.2008-0886

72. Tarar ZI, Zafar MU, Farooq U, Basar O, Tahan V, Daglilar E. The progression of celiac disease, diagnostic modalities, and treatment options. J Investig Med High Impact Case Rep. 2021;9:23247096211053702. DOI: 10.1177/23247096211053702

73. Lamb MM, Miller M, Seifert JA, Frederiksen B, Kroehl M, Rewers M, et al. The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes. 2015 Feb;16(1):31-38. DOI: 10.1111/pedi.12115

74. Knip M, Virtanen SM, Seppä K, Ilonen J, Savilahti E, Vaarala O, et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med. 2010 Nov;363(20):1900-1908. DOI: 10.1056/NEJMoa1004809

75. Hedström AK, Lima Bomfim I, Barcellos L, Gianfrancesco M, Schaefer C, Kockum I, et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology. 2014 Mar;82(10):865-872. DOI: 10.1212/WNL.0000000000000203

76. Liu X, Johnson SB, Lynch KF, Cordan K, Pate R, Butterworth MD, et al. Physical activity and the development of islet autoimmunity and type 1 diabetes in 5- to 15-year-old children followed in the TEDDY Study. Diabetes Care. 2023 Jul;46(7):1409-1416. DOI: 10.2337/dc23-0036

77. Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. 1998 Sep. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews® [Internet]. Seattle: University of Washington; 1998 [updated 2025 Mar; cited 2025 Jul 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1247/

78. Fernandez SV, Huang Y, Snider KE, Zhou Y, Pogash TJ, Russo J. Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. Int J Oncol. 2012 Jul;41(1):369-377. DOI: 10.3892/ijo.2012.1444

79. Qin XY, Fukuda T, Yang L, Zaha H, Akanuma H, Zeng Q, et al. Effects of bisphenol A exposure on the proliferation and senescence of normal human mammary epithelial cells. Cancer Biol Ther. 2012 Mar;13(5):296-306. DOI: 10.4161/cbt.18942

80. Jones LP, Sampson A, Kang HJ, Kim HJ, Yi YW, Kwon SY, et al. Loss of BRCA1 leads to an increased sensitivity to bisphenol A. Toxicol Lett. 2010 Dec;199(3):261-268. DOI: 10.1016/j.toxlet.2010.09.008

81. Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJ, Choi MH, et al. Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2. Sci Transl Med. 2023 Feb;15(684):eade1857. DOI: 10.1126/scitranslmed.ade1857

82. Neirich L, Yahiaoui-Doktor M, Lammert J, Basrai M, Seethaler B, Berling-Ernst A, et al. Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1. Breast Cancer Res Treat. 2021 Dec;190(3):463-475. DOI: 10.1007/s10549-021-06400-7

83. Pijpe A, Manders P, Brohet RM, Collée JM, Verhoef S, Vasen HFA, et al. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat. 2010 Feb;120(1):235-244. DOI: 10.1007/s10549-009-0476-0

84. Ghadirian P, Narod S, Fafard E, Costa M, Robidoux A, Nkondjock A. Breast cancer risk in relation to the joint effect of BRCA mutations and diet diversity. Breast Cancer Res Treat. 2009 Sep;117(2):417-422. DOI: 10.1007/s10549-008-0292-y

85. Guyonnet E, Kim SJ, Pullella K, Zhang CXW, McCuaig JM, Armel S, et al. Vitamin D and calcium supplement use and high-risk breast cancer: a case-control study among BRCA1 and BRCA2 mutation carriers. Cancers (Basel). 2023 May;15(10):2790. DOI: 10.3390/cancers15102790

86. Ko KP, Kim SJ, Huzarski T, Gronwald J, Lubinski J, Lynch HT, et al. The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers. Int J Cancer. 2018 Jun;142(11):2263-2272. DOI: 10.1002/ijc.31257

87. Duelo A, Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, Ruiz-Casares E, Vidal-Carou MC, et al. Pilot study on the prevalence of diamine oxidase gene variants in patients with symptoms of histamine intolerance. Nutrients. 2024 Apr;16(8):1142. DOI: 10.3390/nu16081142

88. García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Ayuso P, Navacerrada F, et al. Diamine oxidase rs10156191 and rs2052129 variants are associated with the risk for migraine. Headache. 2015 Feb;55(2):276-286. DOI: 10.1111/head.12493

89. López García R, Ferrer-Garcia J, Sansalvador A, Quera-Salva MA. Prevalence of diamine oxidase enzyme (DAO) deficiency in subjects with insomnia-related symptoms. J Clin Med. 2024 Aug;13(16):4583. DOI: 10.3390/jcm13164583

90. Okutan G, Ruiz Casares E, Perucho Alcalde T, Sánchez Niño GM, Penadés BF, Terrén Lora A, et al. Prevalence of genetic diamine oxidase (DAO) deficiency in female patients with fibromyalgia in Spain. Biomedicines. 2023 Feb;11(3):660. DOI: 10.3390/biomedicines11030660

91. Blasco-Fontecilla H, Bella-Fernández M, Wang P, Martin-Moratinos M, Li C. Prevalence and clinical picture of diamine oxidase gene variants in children and adolescents with attention deficit hyperactivity disorder: a pilot study. J Clin Med. 2024 Mar;13(6):1659. DOI: 10.3390/jcm13061659

92. Agúndez JAG, Ayuso P, Cornejo-García JA, Blanca M, Torres MJ, Doña I, et al. The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs. PLoS One. 2012;7(11):e47571. DOI: 10.1371/journal.pone.0047571

93. Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, Latorre-Moratalla M, Vidal-Carou MDC. Histamine intolerance: the current state of the art. Biomolecules. 2020 Aug;10(8):1181. DOI: 10.3390/biom10081181